Baystate Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$35.6K Buy
352
+42
+14% +$4.25K ﹤0.01% 437
2023
Q3
$31.6K Buy
310
+50
+19% +$5.1K ﹤0.01% 402
2023
Q2
$26.3K Hold
260
﹤0.01% 421
2023
Q1
$24K Sell
260
-16
-6% -$1.47K ﹤0.01% 436
2022
Q4
$25K Buy
276
+16
+6% +$1.45K ﹤0.01% 426
2022
Q3
$20K Hold
260
﹤0.01% 431
2022
Q2
$22K Hold
260
﹤0.01% 438
2022
Q1
$23K Sell
260
-4
-2% -$354 ﹤0.01% 431
2021
Q4
$23K Hold
264
﹤0.01% 448
2021
Q3
$22K Hold
264
﹤0.01% 405
2021
Q2
$24K Sell
264
-255
-49% -$23.2K ﹤0.01% 370
2021
Q1
$44K Buy
519
+9
+2% +$763 ﹤0.01% 276
2020
Q4
$48K Hold
510
0.01% 253
2020
Q3
$44K Sell
510
-45
-8% -$3.88K 0.01% 234
2020
Q2
$48K Buy
555
+45
+9% +$3.89K 0.01% 229
2020
Q1
$42K Sell
510
-115
-18% -$9.47K 0.01% 206
2019
Q4
$59K Hold
625
0.01% 209
2019
Q3
$54K Buy
625
+115
+23% +$9.94K 0.01% 197
2019
Q2
$47K Sell
510
-59
-10% -$5.44K 0.01% 218
2019
Q1
$40K Buy
569
+11
+2% +$773 0.01% 238
2018
Q4
$44K Hold
558
0.01% 218
2018
Q3
$42K Hold
558
0.01% 225
2018
Q2
$38K Hold
558
0.01% 220
2018
Q1
$39K Hold
558
0.01% 215
2017
Q4
$44K Hold
558
0.01% 212
2017
Q3
$43K Hold
558
0.01% 198
2017
Q2
$42K Sell
558
-670
-55% -$50.4K 0.01% 197
2017
Q1
$81K Buy
1,228
+620
+102% +$40.9K 0.02% 132
2016
Q4
$40K Buy
+608
New +$40K 0.01% 163
2013
Q3
Sell
-642
Closed -$41K 166
2013
Q2
$41K Buy
+642
New +$41K 0.02% 110